chitosan has been researched along with Multiple Myeloma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chinnathambi, A; Gu, X; Meganathan, V; Zhang, H; Zhao, J | 1 |
| Achilefu, S; Alhallak, K; Azab, AK; de la Puente, P; Egbulefu, C; Federico, C; Gilson, RC; Jin, A; King, J; Kohnen, D; Luderer, MJ; Muz, B; Salama, NN; Shah, S; Sun, J; Vij, R | 1 |
| Chen, L; Huang, Z; Li, D; Liu, X; Lou, Y; Lu, B; Xiong, F; Xu, H; Xu, P; Yin, Y; Zhang, X; Zheng, H | 1 |
| Cilurzo, F; Cosco, D; Cristiano, MC; Di Martino, MT; Federico, C; Fresta, M; Maiuolo, J; Paolino, D; Tassone, P | 1 |
| Cao, Z; Li, X; Li, Z; Lin, H; Qian, Z; Wei, Y; Xu, Y; Zhao, Y | 1 |
5 other study(ies) available for chitosan and Multiple Myeloma
| Article | Year |
|---|---|
Anti-cancer potential of selenium-chitosan-polyethylene glycol-carvacrol nanocomposites in multiple myeloma U266 cells.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chitosan; Chlorocebus aethiops; Humans; Multiple Myeloma; Nanocomposites; Reactive Oxygen Species; Selenium; Vero Cells | 2023 |
Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma.
Topics: ADP-ribosyl Cyclase 1; Animals; Antineoplastic Agents; Bortezomib; Cell Line, Tumor; Chitosan; Female; Humans; Membrane Glycoproteins; Mice, SCID; Multiple Myeloma; Nanoparticles; Proteasome Inhibitors | 2018 |
A novel melphalan polymeric prodrug: preparation and property study.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chitosan; Drug Carriers; Glycylglycine; Humans; Melphalan; Multiple Myeloma; Nanoparticles; Polymers; Prodrugs; Solubility | 2014 |
Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma.
Topics: Animals; Antineoplastic Agents; Chitosan; Drug Carriers; Humans; Lactic Acid; Mice; Mice, Inbred NOD; Mice, SCID; MicroRNAs; Multiple Myeloma; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Xenograft Model Antitumor Assays | 2015 |
Camptothecin nanocolloids based on N,N,N-trimethyl chitosan: efficient suppression of growth of multiple myeloma in a murine model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Cell Proliferation; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Colloids; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Stability; Female; Mice; Mice, Inbred BALB C; Multiple Myeloma; Nanoparticles; Solubility; Time Factors; Topoisomerase I Inhibitors; Tumor Burden | 2012 |